Philip chairs the Sydney Catalyst T2/3 Work group and is a member of the Sydney Catalyst Governing council. Philip is also an investigator on the multi-disciplinary, multi-institutional research team that makes up the Sydney Catalyst's Flagship program - EnRICH.
Background:
Philip is the Clinical Director of Cancer Services at the
Concord Repatriation General Hospital and Associate Professor
Medicine, Concord Clinical School. Philip obtained his medical
degree in 1986 from UNSW, completed his FRACP in 1994 and his PhD
from London University in 2000. He worked as a Clinical Research
Fellow from 1995 to 1998 at the Royal Marsden Hospital and has
since worked as a staff specialist in Sydney Local Health District
at Royal Prince Alfred Hospital, Concord Hospital and Chris O'Brien
Lifehouse.
Research Interests:
In clinical practice Philip has a special interest in ovarian,
breast, colorectal and upper gastrointestinal cancers. His research
interests are in drug resistance and designing new platinum
compounds, pharmacological interactions of chemotherapy agents with
herbal compounds and the role of inflammation in cancer drug
metabolism, along with the toxicity of chemotherapy and hormonal
agents in patients with breast cancer.